Evidence map›Paper›PMID 36451198›Full record

ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2022

Right ventricular energetic biomarkers from 4D Flow CMR are associated with exertional capacity in pulmonary arterial hypertension.

Xiaodan Zhao, Shuang Leng, Ru-San Tan, Ping Chai, Tee Joo Yeo, Jennifer Ann Bryant, Lynette L S Teo, Marielle V Fortier, Wen Ruan, Ting Ting Low and 10 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03217240 (Integrated Computational modelIing of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03217240 unknown statusnot on this map

Integrated Computational modelIing of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease ("INITIATE")

TypeobservationalSponsorNational Heart Centre SingaporeRan2017 to 2019Enrolled400ConditionsCongenital Heart Disease, Pulmonary HypertensionArmsCardiac Magnetic Resonance - MRI, Cardiopulmonary Exercise Test, Blood Sampling for all participants
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advances in the imaging of pulmonary hypertension.International journal of cardiology. Congenital heart disease · 2025
    Review
  9. Review
  10. Right heart flow hemodynamic assessment using 4D flow CMR: a systematic review.European heart journal. Imaging methods and practice · 2025
    Review
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failure.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  16. Article
  17. Cardiac MRI in Rheumatic Disease.Rheumatic diseases clinics of North America · 2024
    Review
  18. Article
  19. Article
  20. Age- and sex-specific reference values of biventricular flow components and kinetic energy by 4D flow cardiovascular magnetic resonance in healthy subjects.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2023
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Xiaodan Zhao *National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore.
Shuang Leng *National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore.
Ru-San Tan *National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore.
Ping ChaiNational University Hospital Singapore, Singapore, Singapore. ping_chai@nuhs.edu.sg.
Tee Joo YeoNational University Hospital Singapore, Singapore, Singapore.
Jennifer Ann BryantNational Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore.
Lynette L S TeoNational University Hospital Singapore, Singapore, Singapore.
Marielle V FortierDuke-NUS Medical School, Singapore, Singapore.
Wen RuanNational Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore.
Ting Ting LowNational University Hospital Singapore, Singapore, Singapore.
Ching Ching OngNational University Hospital Singapore, Singapore, Singapore.
Shuo ZhangPhilips Healthcare Germany, Hamburg, Germany.
Rob J van der GeestDepartment of Radiology, Leiden University Medical Center, Leiden, Netherlands.
John C AllenDuke-NUS Medical School, Singapore, Singapore.
Marina HughesDepartment of Cardiovascular Medicine, University of East Anglia, Norwich, UK.
Pankaj GargDepartment of Cardiovascular Medicine, University of East Anglia, Norwich, UK.
Teng Hong TanDuke-NUS Medical School, Singapore, Singapore.
James W YipNational University Hospital Singapore, Singapore, Singapore.
Ju Le TanNational Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore.
Liang ZhongNational Heart Centre Singapore, National Heart Research Institute Singapore, Singapore, Singapore. zhong.liang@nhcs.com.sg.
Duke-NUS Medical School · SGNational Heart Centre Singapore · SGNational University Hospital · SGNational University of Singapore · SGKK Women's and Children's Hospital · SGUniversity of East Anglia · GBLeiden University Medical Center · NLPhilips (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular magnetic resonance (CMR) offers comprehensive right ventricular (RV) evaluation in pulmonary arterial hypertension (PAH). Emerging four-dimensional (4D) flow CMR allows visualization and quantification of intracardiac flow components and calculation of phasic blood kinetic energy (KE) parameters but it is unknown whether these parameters are associated with cardiopulmonary exercise test (CPET)-assessed exercise capacity, which is a surrogate measure of survival in PAH. We compared 4D flow CMR parameters in PAH with healthy controls, and investigated the association of these parameters with RV remodelling, RV functional and CPET outcomes.

methodsPAH patients and healthy controls from two centers were prospectively enrolled to undergo on-site cine and 4D flow CMR, and CPET within one week. RV remodelling index was calculated as the ratio of RV to left ventricular (LV) end-diastolic volumes (EDV). Phasic (peak systolic, average systolic, and peak E-wave) LV and RV blood flow KE indexed to EDV (KEI

results45 PAH patients (46 ± 11 years; 7 M) and 51 healthy subjects (46 ± 14 years; 17 M) with no significant differences in age and gender were analyzed. Compared with healthy controls, PAH had significantly lower median RV direct flow, RV delayed ejection flow, RV peak E-wave KEI

conclusionIn this 4D flow CMR and CPET study, RV direct flow provided incremental value over RVEF for discriminating adverse RV remodelling, impaired exercise capacity, and PAH with intermediate and high risk based on risk score. These data suggest that CMR with 4D flow CMR can provide comprehensive assessment of PAH severity, and may be used to monitor disease progression and therapeutic response. TRIAL REGISTRATION NUMBER: https://www. CLINICALTRIALS: gov . Unique identifier: NCT03217240.

Indexed as

Pulmonary Arterial HypertensionBiomarkersHeart VentriclesHumansMagnetic Resonance SpectroscopyPredictive Value of TestsVentricular RemodelingBiomarkers4D flow CMRCardiopulmonary exercise testFlow componentsKinetic energyPulmonary arterial hypertension

Identifiers

PMID36451198
PMCPMC9714144
OpenAlexW4310639173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.